bioMerieux received FDA Emergency Use Authorization for BIOFIRE COVID-19 test
On Mar. 24, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, had…
On Mar. 24, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, had…
On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
On Mar. 23, 2020, Resverlogix announced that it was seeking to collaborate with organizations currently testing therapies for…
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
On Mar. 23, 2020, the UK Government announced funding of £20 million to support clinicians and scientists in…
On Mar. 23, 2020, Harvard Bioscience announced that it had launched an innovative technology – known as Accumulated…
On Mar. 23, 2020, Heat Biologics announced that it was collaborating with the University of Miami to develop…
On Mar. 23, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the City of Detroit…
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
On Mar. 21, 2020, through its “Peace of Mind” program, Quest Diagnostics took extra measures to ensure individuals…
On Mar. 20, 2020, the U.S. Food and Drug Administration (FDA) issued a new policy that allowed manufacturers…
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…
On Mar. 20, 2020, PRA Health Sciences announced the commercial availability of the COVID-19 Monitoring Program, a mobile…
On Mar. 20, 2020, Chembio Diagnostics announced receipt of a $4 million order from Bio-Manguinhos for the purchase…
On Mar. 20, 2020, Adaptive Biotechnologies and Microsoft announced they were leveraging their existing partnership mapping population-wide adaptive…
On Mar. 19, 2020, Todos Medical announced it had entered into an exclusive distribution agreement for the U.S….
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
On Mar. 19, 2020, Mesa Biotech announced it had been awarded a $561K contract from the U.S. Department…
On Mar. 19, 2020, the Mayo Clinic announced it had significantly expanded its capacity to test clinical samples…
On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…
On Mar. 17, 2020, a small study of macaques found they don’t develop a coronavirus infection the second…
On Mar. 17, 2020, Quidel Corp. announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Mar. 17, 2020, Todos Medical announced a non-exclusive distribution agreement with 3D Biomedicine Science & Technology, a…
On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…
On Mar. 16, 2020, BD (Becton, Dickinson and Company) announced the companies had submitted Emergency Use Authorization requests…
On Mar. 16, 2020, OpGen reported an update on the business of Curetis, the other party to the…
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…
On Mar. 13, 2020, Iceland health authorities and deCode Genetics announced they began comprehensive screening for the virus…
On Mar. 13, 2020, IDEXX Laboratories announced the company had seen no positive results in pets to date…